Penumbra Inc

PENNYSE · USD
319.80USD+0.36 (+0.12%)
629

Penumbra Inc (PEN) Covered Calls

No qualifying covered call setups were found for PEN in the prior session.

Read more

Running PEN covered calls helps you generate consistent income from Penumbra Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Penumbra Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PEN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PEN stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PEN covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Penumbra Inc covered call is worth writing.

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands.

It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Income-focused investors, long-term PEN holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PEN covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Penumbra Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile98.02% Elevated
  • Market cap (M$)12,583
  • 52 weeks high-11.86%
  • 52 weeks low44.37%
  • Analyst recommendationHold
    2.80
  • Target price$363.29
    13.60% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-04
  • P/E78.45
  • Future P/E53.33
  • EPS (ttm)4.07
  • EPS growth next 5 years22.07%

As of September 23, 2026

No illustrative rows to display.

As of September 23, 2026

Sell covered calls with the data behind you

Find the best PEN covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial